Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity for mechanistic research on non-invasive brain stimulation (NIBS) aimed at treating substance use disorders (SUD). This initiative seeks to identify and validate novel NIBS targets while exploring their neurobiological, cognitive, and behavioral effects that may lead to reduced cravings or substance use. The funding, which amounts to up to $1.5 million across fiscal years 2024 to 2026, is intended to support potentially six awards, with applications due by December 16, 2023. Interested applicants must submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, and further details can be found at the provided NIH link or by contacting grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.